Discover the top pharmaceutical companies in India ranked by their market capitalization. These companies are industry leaders contributing significantly to healthcare innovation and the Indian economy.
India is a global leader in generic drug production, supplying 20% of the world's generics and 60% of vaccines by volume. Government initiatives, including the PLI Scheme and Pharmaceutical Technology Upgradation Assistance Scheme, further strengthen the sector.
Market Cap: ₹4,46,684 Crore Sun Pharma is India’s largest pharmaceutical company, offering a diverse range of generic and branded medicines. Based in Mumbai, it serves over 100 markets globally. Data as of 28th December 2024. Source – NSE
Market Cap: ₹1,56,200 Crore Divis Laboratories specializes in active pharmaceutical ingredients (APIs) and intermediates. Headquartered in Hyderabad, it is a trusted name in the global pharma supply chain. Data as of 28th December 2024. Source – NSE
Market Cap: ₹1,21,655 Crore Cipla, headquartered in Mumbai, is renowned for its respiratory and anti-infective medicines. It has a significant presence in both Indian and international markets. Data as of 28th December 2024. Source – NSE
Market Cap: ₹1,18,539 Crore Mankind Pharma is a leader in India’s domestic pharma market, known for over-the-counter products like Manforce Condoms and Prega News. It operates out of New Delhi. Data as of 28th December 2024. Source – NSE
Market Cap: ₹1,16,098 Crore Dr. Reddy's Laboratories, based in Hyderabad, offers affordable and innovative medicines in over 25 countries. It is a key player in the global generic drug industry. Data as of 28th December 2024. Source – NSE
Market Cap: ₹1,15,241 Crore Torrent Pharmaceuticals, headquartered in Ahmedabad, focuses on therapeutic areas such as cardiovascular, central nervous system, and diabetes. It has a robust presence in domestic and global markets. Data as of 28th December 2024. Source – NSE
Market Cap: ₹1,01,631 Crore Lupin, headquartered in Mumbai, excels in manufacturing generics and branded formulations. It is known for its focus on cardiovascular, diabetes, and respiratory segments. Data as of 28th December 2024. Source – NSE
Market Cap: ₹97,851 Crore Zydus Lifesciences, headquartered in Ahmedabad, is a leader in vaccines and biosimilars. Its popular products include Lipaglyn and ZyCoV-D, India's first COVID-19 DNA vaccine. Data as of 28th December 2024. Source – NSE
India's pharmaceutical sector is a cornerstone of the global healthcare landscape. Companies like Sun Pharma, Cipla, and Divis Labs exemplify the industry's excellence, contributing significantly to both domestic and global markets. Data as of 28th December 2024. Source – NSE